QR Kod

Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting

Introduction. Ramucirumab (R) with paclitaxel (PTX) is a global standard for second-line (2L) therapy in advanced gastroesophageal adenocarcinoma (GEA). More and more patients (pts) get treated with taxanes in the perioperative or 1st line metastatic setting. For those pts the benefit of a combinati...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: N. S. Besova, Т. А. Titova, А. А. Tryakin, Е. V. Artamonova, Е. S. Obarevich, D. L. Stroyakovskiy, О. Е. Kalinin, I. S. Stilidi
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: Remedium Group LLC 2021-06-01
Seri Bilgileri:Медицинский совет
Konular:
ramucirumab
disseminated gastric cancer
irinotecan
folfiri
paclitaxel
docetaxel
second line therapy
Online Erişim:https://www.med-sovet.pro/jour/article/view/6212
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller